Concepts for immunotherapies in gliomas
Strategies to empower the immune system to successfully attack cancers, including vaccination approaches, adaptive T cell therapies, and immune checkpoint modulators, have recently achieved remarkable success across a spectrum of cancer indications. Nonetheless, with rare exception, only a minority...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16. März 2018
|
| In: |
Seminars in neurology
Year: 2018, Jahrgang: 38, Heft: 01, Pages: 062-072 |
| ISSN: | 1098-9021 |
| DOI: | 10.1055/s-0037-1620274 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0037-1620274 Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1620274 
|
| Verfasserangaben: | Michael Platten, David A. Reardon |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1697035884 | ||
| 003 | DE-627 | ||
| 005 | 20220818065044.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200504s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/s-0037-1620274 |2 doi | |
| 035 | |a (DE-627)1697035884 | ||
| 035 | |a (DE-599)KXP1697035884 | ||
| 035 | |a (OCoLC)1341318196 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 245 | 1 | 0 | |a Concepts for immunotherapies in gliomas |c Michael Platten, David A. Reardon |
| 264 | 1 | |c 16. März 2018 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.05.2020 | ||
| 520 | |a Strategies to empower the immune system to successfully attack cancers, including vaccination approaches, adaptive T cell therapies, and immune checkpoint modulators, have recently achieved remarkable success across a spectrum of cancer indications. Nonetheless, with rare exception, only a minority of patients with a given type of cancer respond to an immunotherapeutic when administered as single-agent therapy. Although under extensive laboratory and clinical investigation, the role of these approaches for glioma patients remains to be determined. While the central nervous system (CNS) is no longer regarded as an immunoprivileged sanctuary, nuances regarding immune responses in the CNS may impact on the activity of immunotherapy treatments of brain tumor patients. Furthermore, many common CNS tumors such as World Health Organization grade III and IV (high grade) gliomas utilize myriad, nonoverlapping strategies to dampen or extinguish antitumor immune responses. For these reasons, critical research efforts are focused on identifying biomarkers that predict patients with a heightened likelihood of therapeutic benefit as well as evaluating rationally designed combinatorial immunotherapy approaches with potentially complementary mechanisms of immune-activation for brain cancer patients. | ||
| 700 | 1 | |a Reardon, David A. |e VerfasserIn |0 (DE-588)1081843225 |0 (DE-627)846734494 |0 (DE-576)454837860 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in neurology |d New York, NY : Thieme Medical Publ., 1981 |g 38(2018), 01, Seite 062-072 |h Online-Ressource |w (DE-627)342892835 |w (DE-600)2072477-9 |w (DE-576)279447876 |x 1098-9021 |7 nnas |a Concepts for immunotherapies in gliomas |
| 773 | 1 | 8 | |g volume:38 |g year:2018 |g number:01 |g pages:062-072 |g extent:11 |a Concepts for immunotherapies in gliomas |
| 856 | 4 | 0 | |u https://doi.org/10.1055/s-0037-1620274 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1620274 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200504 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 60000 |d 62700 |e 60000PP121627780 |e 62700PP121627780 |k 0/60000/ |k 1/60000/62700/ |p 1 |x j | ||
| 999 | |a KXP-PPN1697035884 |e 3656824878 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Platten","given":"Michael","role":"aut","display":"Platten, Michael"},{"family":"Reardon","given":"David A.","role":"aut","display":"Reardon, David A."}],"relHost":[{"pubHistory":["1.1981 -"],"origin":[{"dateIssuedKey":"1981","dateIssuedDisp":"1981-","publisherPlace":"New York, NY ; Stuttgart","publisher":"Thieme Medical Publ."}],"part":{"volume":"38","year":"2018","extent":"11","text":"38(2018), 01, Seite 062-072","issue":"01","pages":"062-072"},"title":[{"title":"Seminars in neurology","title_sort":"Seminars in neurology"}],"id":{"zdb":["2072477-9"],"doi":["10.1055/s-00000071"],"eki":["342892835"],"issn":["1098-9021"]},"note":["Gesehen am 28.06.2017"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"342892835","physDesc":[{"extent":"Online-Ressource"}],"disp":"Concepts for immunotherapies in gliomasSeminars in neurology"}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"16. März 2018"}],"title":[{"title_sort":"Concepts for immunotherapies in gliomas","title":"Concepts for immunotherapies in gliomas"}],"note":["Gesehen am 04.05.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1697035884","physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Michael Platten, David A. Reardon"]},"id":{"eki":["1697035884"],"doi":["10.1055/s-0037-1620274"]}} | ||
| SRT | |a PLATTENMICCONCEPTSFO1620 | ||